Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Infusion in Lower Limb Amputation
NCT05830630Recruiting
- Sponsor
- Tanta University
- Start
- May 2023
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of methylene blue in postoperative pain and phantom limb pain (PLP) (2 arms), sponsored by Tanta University. Primary endpoint: Degree of postoperative pain at 3 days. Started May 2023; status: recruiting.
02
Drugs
methylene blue
03
Conditions
postoperative painphantom limb pain (PLP)
Beyond the preview
Go deeper on NCT05830630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05830630.